Mc3r agonist peptides
US-2024287154-A1 · Aug 29, 2024 · US
Melanocyte-stimulating hormone [MSH]
Melanocyte-stimulating hormone [MSH] · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/68 |
| Official title | Melanocyte-stimulating hormone [MSH] |
| Display label | Melanocyte-stimulating hormone [MSH] |
| Total patents | 63 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 7 |
| 2016 | 9 |
| 2017 | 12 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Melanocortin receptor ligands modified with hydantoin
US-2024182519-A1 · Jun 6, 2024 · US
Cyclic peptide analogs of melanocortin and amanitin and methods of making such
US-11884714-B2 · Jan 30, 2024 · US
Bovine adrenal medulla peptide 8-22 compounds and methods of use thereof for treating pain
US-11718646-B2 · Aug 8, 2023 · US
Melanocortin 1 receptor ligands and methods of use
US-2023167154-A1 · Jun 1, 2023 · US
Cyclic peptide analogs of melanocortin and amanitin and methods of making such
US-2022298219-A1 · Sep 22, 2022 · US
Cyclic peptide analogs of melanocortin and amanitin and methods of making such
US-11396535-B2 · Jul 26, 2022 · US
Conjugation of mcr1 ligand with cytotoxic drugs for treating skin cancer
US-2022143196-A1 · May 12, 2022 · US
Melanocortin 1 receptor ligands and methods of use
US-11230568-B2 · Jan 25, 2022 · US
Modulators of melanocortin receptors
US-11124542-B2 · Sep 21, 2021 · US
Compounds Capable of Binding to Melanocortin 4 Receptor
US-2021221867-A1 · Jul 22, 2021 · US
Melanocortin receptor ligands modified with hydantoin
US-2021163536-A1 · Jun 3, 2021 · US
Compounds and methods for treating pain
US-2021101934-A1 · Apr 8, 2021 · US
Cyclic peptide analogs of melanocortin and amanitin and methods of making such
US-2021024605-A1 · Jan 28, 2021 · US
Compounds and methods for treating pain
US-10899796-B2 · Jan 26, 2021 · US
Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N
US-10653743-B2 · May 19, 2020 · US
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
US-2020123216-A1 · Apr 23, 2020 · US
Compositions and methods for treating central nervous system (CNS) disorders and mood disorders
US-10550157-B2 · Feb 4, 2020 · US
Melanocortin 1 receptor ligands and methods of use
US-2020002376-A1 · Jan 2, 2020 · US
Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
US-10464985-B2 · Nov 5, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/68?
- CPC C07K14/68 is the Cooperative Patent Classification code for “Melanocyte-stimulating hormone [MSH].”
- How many patents are filed under CPC C07K14/68 (Melanocyte-stimulating hormone [MSH])?
- Our database includes 63 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/68 growing?
- Publication counts under this code: 4 in 2024 vs 2 in 2025 (latest complete years).